tgindex
T

Trade With Swapnil

Статистика
@Tradewithswapnil550английский

Trading Psychology || Investing Knowledge || Charts || NISM RA Certified Disclaimer : We are not SEBI registered. Charts and Views Provided are for educational purposes. Do your due diligence before considering the position. Contact: @Swaps738

Последний пост
07:27
Последнее чтение
ещё не заходили
Постов за неделю
39
Всего постов
128
Тип
открытый
Язык
английский
В каталоге с
14 авг.
Подписчики
11 292
−29 за 4 дн.
Сутки
−7
−0,06%
Неделя
 
Месяц
 
Просмотров на пост
1 420
40 постов
Вовлечённость
12,6%
к подписчикам
Постов в день
5,6
всего 128
Упоминаний
0
каналов
Охват размещения
оценка
1/24сутки в ленте
1 121
1/48двое суток
1 284
1/72трое суток
1 385

Оценка по просмотрам недавних постов: пост набирает почти всё за первые сутки.

Посты

  • Good Morning, Here is the Mentorship group: Here is the group where I share Daily pre and post market data! Stocks that I trade for swing / positional with detailed logic with chart explanation. Screener for stock selection. DM open for queries on charts, logics, market info... Link:👇 https://cosmofeed.com/vig/68283cc136d04400134fccd1

  • 07:102912

    Laser Power Good move Result reaction has happened and it was at 280 Now at 328.

  • 06:374634

    Indo MIM perfect reversal and results were also pretty good Made a high of 950 from 800 zone. And today locked in UC

  • 18:2288520

    Any stock you are buying Your risk Your money Your profits Please do your due diligence! I share what I see on charts, stocks may go up and down because the stock market is a probability game! Please note i personally don't ping you nor do I share anything to buy. Please don't share any OTP, passwords or login credentials with anyone. Always do your due diligence first. One more thing their is no schemes of making only profit from stock market or crypto. If someone says it that means they are lying. Have a great day!

  • 11:371 0554

    Azad engineering 2900+ now from 2000 zone levels.

  • 10:121 1068

    Apollo Micro Systems has secured new orders worth ₹80.84 crore from: • Defence PSUs • State Governments • Private Industries

  • 09:061 0975

    Premier Explosive started a little movement now Now stock is exactly around 21 and 10 EMA and back to zone

  • 17 авг.1 17210

    Brokerage views ! M&M: Citi maintains Buy, TP ₹4,260. BE 6 SPORTEQ launched with Battery-as-a-Service at ₹11.5L; battery cost ₹3.75/km. OTA software upgrades for BE 6, XEV 9e & XEV 9S from Jan’27. Deliveries from Aug 26. Nomura: Buy, TP ₹4,875. Global pick-up targets a ~1mn-unit annual market; even 3–5% share could mean 30–50k units annually. Global competition & brand acceptance key monitorables. IGL: Nomura downgrades to Neutral, TP ₹155; Delhi EV policy may pressure CNG volumes, while Q1 margin disappointment keeps pressure intact. CLSA remains Outperform, TP ₹195, but cuts FY27/FY28 EPS by 16%/7%. Voltas: Citi Buy ₹1,550; RAC volumes +45% YoY and secondary market share at 17.3%. Atomberg JV targets 28L compressor capacity. CLSA Underperform ₹1,160, while Nomura is Neutral ₹1,357 and UBS Buy ₹1,560 — margin recovery remains the key debate. PTC Industries: Goldman Sachs Buy, TP ₹25,770. Q1 revenue +97% YoY; titanium/superalloy contracts, Airbus, BrahMos and MoD opportunities support growth. NMDC: Citi & Goldman Sachs retain Sell, TPs ₹80/₹84. Higher costs and weaker realisations weigh on Q1; recent price cuts and seasonally weak Q2 add pressure. Ashok Leyland: GS Neutral ₹175; CLSA Outperform ₹196; Nomura Neutral ₹194. Demand remains healthy, with margin recovery expected from Q3FY27. Amber Enterprises: JPMorgan upgrades to Overweight, TP ₹8,350. FY27 consumer durables growth guidance raised to 13–15%, EBITDA margin to ~8%; mobile production on track for Q1FY28. Max Healthcare: CLSA Outperform ₹1,160; JPMorgan & UBS Buy/Overweight ₹1,300. Q1 performance ahead of estimates; brownfield bed additions to drive growth, with occupancy at 75%. Belrise: Jefferies Buy, TP ₹250. Q1 EBITDA +5% YoY and 4% above estimates; strong growth across 2W, PV and CV segments. Alkem Labs: JPMorgan Neutral ₹6,100; Macquarie Underperform ₹4,900. India growth remains soft, while higher opex and near-term margin dilution from Occlutech/Enzene limit earnings momentum.

  • 17 авг.1 0755

    PM Modi-Independence Day Speech & Stock Impact 1.One crore youth to be trained in AI over the next year Positive for NIIT, NIIT Learning, Aptech 2.Free online coaching for students preparing for competitive examinations Negative for Physicswallah, Veranda Learning 3. Civil defence reform and defence manufacturing push Positive for HAL, BEL, Solar Industries, Bharat Forge 4. Sports talent hunt for children aged 5 to 15 No direct listed play 5. Semiconductor push: More fabrication plants planned+ five to eight more plants were expected to be established in the coming years, Positive for CG Power, Kaynes, Dixon Tech, Tata Elxsi, Moschip Tech 6. Nuclear energy: 100 GW target by 2047 Positive for HCC, Walchandnagar, L&T, BHEL, NTPC 7. Insurance for All by 2047 To make health and life policies cheaper Slight Negative for private insurance players, neutral for LIC

  • 15 авг.1 26333

    A term plan. Family insured. No debt. A home. An understanding partner. Life feels lighter, that's enough.

  • 15 авг.1 2976

    Anupam Rasayan – Management Words 🧵 Total Income: Grew by a strong 36% YoY to ₹668 crore. EBITDA Growth: Increased by 35% YoY to ₹175 crore, with a stable EBITDA margin of 26%. Profit After Tax (PAT): Stood at ₹51 crores, a modest 6% YoY growth, impacted by higher depreciation and interest costs. Cash Profit: Reported at ₹64 crores, up from ₹56 crores in Q1 FY26. Capex Cycle: The major capex cycle has been completed, with future requirements expected to be minimal at around ₹70-80 crores for the standalone entity. 2. Strategic Initiatives & Acquisitions J-Hawk Integration: Now in its first full year of consolidation, J-Hawk contributed 20-22% of Q1 revenue with robust EBITDA margins of 19-20%. Bliss GVS Pharma Acquisition: The process is on track and expected to be completed by the first half of September. The open offer concluded successfully with insignificant tendering. Future API Plant: The company is actively exploring the acquisition of an API facility to create an integrated pharma platform, a decision to be finalised post-consolidation with Bliss management. Synergies: Management is working with Bain & Co. to realise synergies between Anupam and J-Hawk, particularly in the high-value semiconductor and electronics portfolio. 3. Business & Operational Updates LOI with BASF: Signed a Letter of Intent (LOI) for a potential long-term supply deal worth approximately US $300 million over 10 years, with commercialisation expected in FY27. Order Book: Cumulative signed LOIs and contracts represent a potential business of ₹18,000 crores over their respective tenures. Segment Performance: The share of the polymers business has increased significantly and is expected to be 30-35% of consolidated revenue going forward. Agrochemicals: The segment is witnessing demand recovery and is expected to remain stable, though growing at a slower pace than the pharma and performance materials segments. 4. New Products & Technology ETFA Commercialisation: Became the first company globally to commercialise ethyl trifluoroacetate (ETFA) using advanced flow chemistry, enhancing process safety, quality, and scalability. ETFA Market Opportunity: The addressable market for this molecule is estimated at half a billion dollars, with the company targeting a market share of 15-30% in the long term. New Launches: Commercialised one new pharma product and two new performance materials products during the quarter. R&D Pipeline: A strong pipeline of 65+ pharma and polymer molecules is currently in the R&D and pilot stages. 5. Guidance & Outlook Revenue Growth: Management expects 20-25% organic revenue growth, supplemented by an additional 10-15% from the J-Hawk consolidation. EBITDA Margin: Guidance for the standalone EBITDA margin is maintained at 24-26%, while the consolidated margin is expected to be between 22 and 24%. Working Capital: The company remains focused on improving working capital efficiency in FY27 through tighter management of inventory and receivables. Semiconductor Business: Seeing very strong traction and growth, which is being accelerated by the integration of J-Hawk's portfolio and customer access.

  • 15 авг.1 22310

    Wishing you all happy Independence day❤️

  • 14 авг.1 42210

    Indo MIM Perfect bounce from support level High of 852 today!!

  • 14 авг.1 59110

    Minda Corp Then 540 Now 760 Superb move Even results are also super!

  • без подписи

  • 14 авг.1 59610

    Premier Explosive and Apollo Micro Daily time frame chart Both almost similar.

  • 14 авг.1 5707

    Premier Explosive not going downside Actually its flat ever after bad results. Market has factored in the results which is good sign. I will definitely watchout it!!

  • 14 авг.1 4662

    Any trade if you are taking it trade with SL mandatory

  • 14 авг.1 6812

    📢 IPO Events | 14 Aug 2026 Live : Fascinate Textiles Ltd (NSE SME) Credent Connect N Care Ltd. (NSE SME) Opening Today: Skytech Infinite Platform Ltd. (NSE SME) ENS Enterprises Ltd (BSE SME) Technocrats Plasma Systems Ltd. (BSE SME) Closing Today : Shiprocket Ltd (MAINBOARD) Pramodini Medicare Ltd. (NSE SME) Behari Lal Engineering Ltd (MAINBOARD) Q&T Foods Ltd. (BSE SME) Allotment Today : Milky Mist Dairy Food Ltd. (MAINBOARD) Sham Foam Ltd (BSE SME) Listing Today : LEAP India Ltd (MAINBOARD) Technocraft Ventures Ltd. (Mainboard) Optimystix Entertainment India Ltd (NSE SME)

  • 14 авг.1 3645

    Apollo Micro is one of the stock where FIIs are adding aggressively.